Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction

Yang Hu, Ying Chen, Lexi Ding, Xuemin He, Yusuke Takahashi, Yang Gao, Wei Shen, Rui Cheng, Qian Chen, Xiaoping Qi, Michael E. Boulton, Jian Xing Ma

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Two independent clinical studies have reported that fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, has robust therapeutic effects on microvascular complications of diabetes, including diabetic retinopathy (DR) in type 2 diabetic patients. However, the expression and function of PPARα in the retina are unclear. Here, we demonstrated that PPARα is expressed in multiple cell types in the retina. In both type 1 and type 2 diabetes models, expression of PPARα, but not PPARβ/δ or PPARγ, was significantly down-regulated in the retina. Furthermore, highglucose medium was sufficient to down-regulate PPARα expression in cultured retinal cells. To further investigate the role of PPARα in DR, diabetes was induced in PPARα knockout (KO) mice and wild-type (WT) mice. Diabetic PPARα KO mice developed more severe DR, as shown by retinal vascular leakage, leukostasis, pericyte loss, capillary degeneration, and over-expression of inflammatory factors, compared with diabetic WT mice. In addition, overexpression of PPARα in the retina of diabetic rats significantly alleviated diabetes-induced retinal vascular leakage and retinal inflammation. Furthermore, PPARα overexpression inhibited endothelial cell migration and proliferation. These findings revealed that diabetes-induced down-regulation of PPARα plays an important role in DR. Up-regulation or activation of PPARα may represent a novel therapeutic strategy for DR.

Original languageEnglish
Pages (from-to)15401-15406
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number38
DOIs
StatePublished - Oct 17 2013

Fingerprint

Peroxisome Proliferator-Activated Receptors
Down-Regulation
Diabetic Retinopathy
Retina
Retinal Vessels
Knockout Mice
Leukostasis
Fenofibrate
Pericytes
Therapeutic Uses
Diabetes Complications
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Cell Movement

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. / Hu, Yang; Chen, Ying; Ding, Lexi; He, Xuemin; Takahashi, Yusuke; Gao, Yang; Shen, Wei; Cheng, Rui; Chen, Qian; Qi, Xiaoping; Boulton, Michael E.; Ma, Jian Xing.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 38, 17.10.2013, p. 15401-15406.

Research output: Contribution to journalArticle

Hu, Y, Chen, Y, Ding, L, He, X, Takahashi, Y, Gao, Y, Shen, W, Cheng, R, Chen, Q, Qi, X, Boulton, ME & Ma, JX 2013, 'Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction', Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 38, pp. 15401-15406. https://doi.org/10.1073/pnas.1307211110
Hu, Yang ; Chen, Ying ; Ding, Lexi ; He, Xuemin ; Takahashi, Yusuke ; Gao, Yang ; Shen, Wei ; Cheng, Rui ; Chen, Qian ; Qi, Xiaoping ; Boulton, Michael E. ; Ma, Jian Xing. / Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 38. pp. 15401-15406.
@article{27a8c2ae83e14d3aa6f00d50731b7c50,
title = "Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction",
abstract = "Two independent clinical studies have reported that fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, has robust therapeutic effects on microvascular complications of diabetes, including diabetic retinopathy (DR) in type 2 diabetic patients. However, the expression and function of PPARα in the retina are unclear. Here, we demonstrated that PPARα is expressed in multiple cell types in the retina. In both type 1 and type 2 diabetes models, expression of PPARα, but not PPARβ/δ or PPARγ, was significantly down-regulated in the retina. Furthermore, highglucose medium was sufficient to down-regulate PPARα expression in cultured retinal cells. To further investigate the role of PPARα in DR, diabetes was induced in PPARα knockout (KO) mice and wild-type (WT) mice. Diabetic PPARα KO mice developed more severe DR, as shown by retinal vascular leakage, leukostasis, pericyte loss, capillary degeneration, and over-expression of inflammatory factors, compared with diabetic WT mice. In addition, overexpression of PPARα in the retina of diabetic rats significantly alleviated diabetes-induced retinal vascular leakage and retinal inflammation. Furthermore, PPARα overexpression inhibited endothelial cell migration and proliferation. These findings revealed that diabetes-induced down-regulation of PPARα plays an important role in DR. Up-regulation or activation of PPARα may represent a novel therapeutic strategy for DR.",
author = "Yang Hu and Ying Chen and Lexi Ding and Xuemin He and Yusuke Takahashi and Yang Gao and Wei Shen and Rui Cheng and Qian Chen and Xiaoping Qi and Boulton, {Michael E.} and Ma, {Jian Xing}",
year = "2013",
month = "10",
day = "17",
doi = "10.1073/pnas.1307211110",
language = "English",
volume = "110",
pages = "15401--15406",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "38",

}

TY - JOUR

T1 - Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction

AU - Hu, Yang

AU - Chen, Ying

AU - Ding, Lexi

AU - He, Xuemin

AU - Takahashi, Yusuke

AU - Gao, Yang

AU - Shen, Wei

AU - Cheng, Rui

AU - Chen, Qian

AU - Qi, Xiaoping

AU - Boulton, Michael E.

AU - Ma, Jian Xing

PY - 2013/10/17

Y1 - 2013/10/17

N2 - Two independent clinical studies have reported that fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, has robust therapeutic effects on microvascular complications of diabetes, including diabetic retinopathy (DR) in type 2 diabetic patients. However, the expression and function of PPARα in the retina are unclear. Here, we demonstrated that PPARα is expressed in multiple cell types in the retina. In both type 1 and type 2 diabetes models, expression of PPARα, but not PPARβ/δ or PPARγ, was significantly down-regulated in the retina. Furthermore, highglucose medium was sufficient to down-regulate PPARα expression in cultured retinal cells. To further investigate the role of PPARα in DR, diabetes was induced in PPARα knockout (KO) mice and wild-type (WT) mice. Diabetic PPARα KO mice developed more severe DR, as shown by retinal vascular leakage, leukostasis, pericyte loss, capillary degeneration, and over-expression of inflammatory factors, compared with diabetic WT mice. In addition, overexpression of PPARα in the retina of diabetic rats significantly alleviated diabetes-induced retinal vascular leakage and retinal inflammation. Furthermore, PPARα overexpression inhibited endothelial cell migration and proliferation. These findings revealed that diabetes-induced down-regulation of PPARα plays an important role in DR. Up-regulation or activation of PPARα may represent a novel therapeutic strategy for DR.

AB - Two independent clinical studies have reported that fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, has robust therapeutic effects on microvascular complications of diabetes, including diabetic retinopathy (DR) in type 2 diabetic patients. However, the expression and function of PPARα in the retina are unclear. Here, we demonstrated that PPARα is expressed in multiple cell types in the retina. In both type 1 and type 2 diabetes models, expression of PPARα, but not PPARβ/δ or PPARγ, was significantly down-regulated in the retina. Furthermore, highglucose medium was sufficient to down-regulate PPARα expression in cultured retinal cells. To further investigate the role of PPARα in DR, diabetes was induced in PPARα knockout (KO) mice and wild-type (WT) mice. Diabetic PPARα KO mice developed more severe DR, as shown by retinal vascular leakage, leukostasis, pericyte loss, capillary degeneration, and over-expression of inflammatory factors, compared with diabetic WT mice. In addition, overexpression of PPARα in the retina of diabetic rats significantly alleviated diabetes-induced retinal vascular leakage and retinal inflammation. Furthermore, PPARα overexpression inhibited endothelial cell migration and proliferation. These findings revealed that diabetes-induced down-regulation of PPARα plays an important role in DR. Up-regulation or activation of PPARα may represent a novel therapeutic strategy for DR.

UR - http://www.scopus.com/inward/record.url?scp=84884343947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884343947&partnerID=8YFLogxK

U2 - 10.1073/pnas.1307211110

DO - 10.1073/pnas.1307211110

M3 - Article

C2 - 24003152

AN - SCOPUS:84884343947

VL - 110

SP - 15401

EP - 15406

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 38

ER -